FindTrial
Sign In

Anesthesia management of covid-19 associated ROC mucormycosis

Perioperative anesthetic management of covid-19 associated rhinoorbitocerebral mucormycosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/01/039622
Enrollment
50
Registered
2022-01-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Ashwini Yadavrao Sontakke
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients posted for emergency or elective surgical resection of rhiniorbitocerebral mucormycosis under general anaesthesia

Exclusion criteria

Exclusion criteria: Lack of patients consent coagulopathy

Design outcomes

Primary

MeasureTime frame
1.Study the outcome of patients in following parameters Requirement of inotropic support, ventilator support, ICU stay, total duration of hospitalization, co-morbid condition affecting the outcome 2.Mortality rate and average mortality timeTimepoint: 1.Before Surgery 2.Intraoperative 3.Immediate postoperative 4.Till discharge / Death 5.30 days—

Secondary

MeasureTime frame
Early debidement of disease and outcome of patients. 5.co-relation between predisposing factors and outcome of patients Timepoint: till dischage—

Countries

India

Contacts

Public ContactDr Ashwini Yadavrao Sontakke

Dr. Shankarrao Chavan Government Medical College, Nanded

anaesthesiascgmcnanded@gmail.com8087330897

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026